Pharmacological inhibition of WEE1 kinase activity and the consequent removal of the G2–M checkpoint through the CDK1 hyperactivation represents an attractive strategy to drive cancer cells to enter into unscheduled mitosis and, arguably, to undergo cell death via alternative mechanisms such as the mitotic catastrophe [20]. The gene discussed is CDK1; the disease is cancer.